FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, namely to murine monoclonal antibodies, which correspond to monoclonal antibodies isolated by hybridoma 3G8/C11 and 7G4/A12 cell lines, and which respond to M-antigen hMPV. These antibodies do not conflict with each other over the binding site when binding with the antigen, as well as do not prevent simultaneous binding with the antigen.
EFFECT: monoclonal antibodies can be used in tests for detection, diagnosis and/or detection of hMPV infection.
8 cl, 6 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MONOCLONAL ANTIBODIES WITH ANTIGEN ORIENTATION P OF HUMAN RESPIRATORY SYNCYTIAL VIRUS, OBTAINED AND SECRETED FROM CELL HYBRIDOMAS, USED FOR DETECTION AND DIAGNOSIS OF INFECTION CAUSED BY RESPIRATORY SYNCYTIAL VIRUS | 2016 |
|
RU2716990C2 |
| MONOCLONAL ANTIBODY TO RDB FRAGMENT IN COMPOSITION OF SARS-COV-2 S PROTEIN | 2020 |
|
RU2744274C1 |
| ISOLATED POLYPEPTIDES BASED ON NEUTRALISING OF PROTEIN p17 OF HIV VIRUS, USED AS VACCINES, AND NEUTRALISING ANTI-p17-ANTIBODIES, SPECIFICALLY RECOGNISING SAID NEUTRALISING | 2002 |
|
RU2337922C9 |
| RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTI-G PROTEIN ANTIBODIES | 2008 |
|
RU2526517C2 |
| EXOSOMES AND THEIR USE AS VACCINE | 2016 |
|
RU2763524C2 |
| NOVEL ANTI-IL13 ANTIBODIES AND USE THEREOF | 2004 |
|
RU2487887C2 |
| MONOCLONAL ANTI-CD20-ANTIBODY | 2006 |
|
RU2415871C2 |
| MONOCLONAL ANTIBODIES AGAINST IL-21 OF HUMAN BEING | 2008 |
|
RU2504552C2 |
| VIRUS OF CAPRINE ARTHRITIS-ENCEPHALITIS PROVIDING IMMUNE PROTECTION AGAINST HIV- 1 INFECTION | 1997 |
|
RU2194529C2 |
| ANTI-PD-1 ANTIBODY AND USE THEREOF | 2017 |
|
RU2739610C1 |
